mivacurium

Anesthesiology A short-acting nondepolarizing muscle relaxing anesthetic, a congener of atracurium. See Atracurium, Muscle relaxant, Nondepolarizing agent. Cf Depolarizing agent.

mivacurium

A non-depolarizing muscle-relaxant drug used by anaesthetists. The drug acts withing 3–4 minutes and its effect lasts for about 15 minutes. Mivacurium is rapidly broken down by CHOLINESTERASE in the blood. A brand name is Mivacron.

Mentioned in ?

References in periodicals archive ?

* Suxamethonium and mivacurium for intubation should not be used in patients with OPP, and alternative muscle relaxants should be considered.

Prolonged paralysis in a child with organophosphate pesticide poisoning

Randomized double-blinded comparison of fentanyl, mivacurium or placebo to facilitate laryngeal mask airway insertion.

Comparative study on conditions for LMA insertion with two different low doses of succinylcholine following thiopentone induction

Table One: Sample list of neuromuscular blocking agents available in Canada Generic Name Common Trade Name atracurium Tracrium cisatracurium Nimbex mivacurium Mivacron pancuronium Pavulon succinylcholine ([dagger]) Quelicin ([dagger]) tubocurarine Tubarine vecuronium Norcuron ([dagger]) Depolarizing neuromuscular blocking agent.

Neuromuscular blocking agents: enhancing safety by reducing the risk of accidental administration

The Chemistry Unit quickly developed and validated a method for mivacurium analysis.

Investigative services

The infusion rate of mivacurium and spontaneous neuromuscular recovery in magnesium-treated parturients.

Pre-treatment with magnesium sulphate before non-depolarizing muscle relaxants: effect on speed on onset, induction and recovery

For both periods, the usage of NMBA (succinylcholine, mivacurium, atracurium, cis-atracurium, vecuronium and rocuronium), reversal agents (neostigmine, glycopyrrolate, atropine and sugammadex) and associated costs as well as descriptors of the case mix for each month (including patient age, gender, American Society of Anesthesiologists physical status, urgency of operation, surgical specialty, times of surgery, anaesthesia and PACU stay, time from surgery to discharge) were documented.

Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs

Other agents include cistracurium, doxacurium and mivacurium, all of which have onsets within a few minutes and can last for about an hour.

Neuromuscular blocking agents and the physiology of the neuromuscular junction

Prolonged post-succinylcholine (SC)1 apnea is an uncommon but serious adverse event that follows administration of SC or mivacurium, with an incidence estimated at 1 per 1800 anaesthetic cases (1).

Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population

Maintenance of muscle relaxation was facilitated by 0.1 mg [kg.sup.-1] mivacurium. Ventilation was adjusted to keep end-tidal [CO.sub.2] at 35 mmHg.

Comparison of Patient Satisfaction Between General and Spinal Anaesthesia in Emergency Caesarean Deliveries./Acil Sezaryen Operasyonlarinda Genel ve Spinal Anestezinin Hasta Memnuniyeti Yonunden Karsilastirilmasi

[6] Furthermore, when compared with Mivacurium and Suxamethonium both Rocuronium and Mivacurium were found to be good alternative for Suxamethonium.

Comparison of Rocuronium Bromide with Suxamethonium chloride for tracheal intubation

The conclusions were that neither vecuronium 0.07 mg/kg (5) nor mivacurium 0.08 mg/kg (6) were as effective as succinylcholine.

With the advent of sugammadex, a succinylcholine-free anaesthetic in electroconvulsive therapy may be the future standard

Rocuronium has been evaluated previously as a precurarisation agent; it demonstrates superior effectiveness compared with d-tubocurarine, vecuronium, atracurium and mivacurium in preventing fasciculations and post-succinylcholine myalgias.

Pretreatment with lidocaine for preventing the withdrawal movements associated with intravenous injection of rocuronium--a prospective, double blinded, randomised and placebo control study